MARKET

NERV

NERV

Minerva Neurosci
NASDAQ
2.580
-0.050
-1.90%
After Hours: 2.540 -0.04 -1.55% 17:23 03/04 EST
OPEN
2.650
PREV CLOSE
2.630
HIGH
2.650
LOW
2.470
VOLUME
153.50K
TURNOVER
0
52 WEEK HIGH
13.49
52 WEEK LOW
1.500
MARKET CAP
18.04M
P/E (TTM)
-0.5594
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NERV last week (0226-0301)?
Weekly Report · 12h ago
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
The Dow Jones index fell more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28%. J.M. Smucker Company posted better-than-expected earnings for its fourth quarter. Utilities shares rose by 1.2% on Tuesday as energy shares fell by 0.4%. Asian markets closed higher on Tuesday while European shares closed mixed.
Benzinga · 6d ago
Health Care Sector Update for 02/27/2024: VKTX, CAPR, NERV
NASDAQ · 6d ago
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Helix Energy Solutions Group, Inc. Shares dipped 11% to $9.13 on Tuesday. The company posted weak earnings of 6 cents per share. Janux Therapeutics shares jumped 145% after the company announced updated clinical data for both of its clinical programs. Other stocks moving in Tuesday's mid-day session included Viking Therapeutic and Presto Automation.
Benzinga · 6d ago
Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
FDA issued a Complete Response Letter to Minerva Neurosciences Inc's marketing application for roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company's shares are trading lower after the FDA issued the CRL. The FDA cited the company's application lacks clinical deficiencies.
Benzinga · 6d ago
BBAI, CTMX and STRC among mid-day movers
On the Move BBAI, CTMX and STRC among mid-day movers. Janux Therapeutics and BigBear.ai Holdings were among the biggest gainers. Minerva Neurosciences was among the companies that lost ground in the biotech sector.
Seeking Alpha · 6d ago
HC Wainwright & Co. Reiterates Neutral on Minerva Neurosciences, Maintains $11 Price Target
Benzinga · 6d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Janux Therapeutics (NASDAQ:JANX) stock increased by 189.9% to $43.78 during Tuesday's regular session. The company's market cap stands at $2.0 billion. Viking Therapeutic shares moved upwards by 91.96% as the company's Q4 earnings report came out.
Benzinga · 6d ago
More
About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company's lead product candidates are roluperidone (MIN-101) and MIN-301. Roluperidone (MIN-101) is a compound that blocks serotonin, sigma, and α adrenergic receptors that are involved in the regulation of mood, cognition, sleep, and anxiety. The Company is developing roluperidone to treat patients with schizophrenia. Roluperidone is designed to block a specific subtype of serotonin receptor called 5-HT2A. The Company’s MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, for the treatment of Parkinson’s disease and for other neurodegenerative disorders. The Company is also developing seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD).

Webull offers Minerva Neurosciences Inc stock information, including NASDAQ: NERV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NERV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NERV stock methods without spending real money on the virtual paper trading platform.